
    
      Please see the following review articles on this topic:

      Shoelson SE, Lee J, Goldfine AB. (2006) Inflammation in insulin resistance. J. Clin. Invest.
      116, 1793-1801.

      Goldfine AB, Fonseca V and Shoelson SE (2010) Therapeutic approaches to target inflammation
      in type 2 diabetes. Clin Chem. 57, 162-167.

      Donath MY and Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol.
      11, 98-107.

      Goldfine AB and Shoelson SE (2017) Therapeutic approaches targeting inflammation for diabetes
      and associated cardiovascular risk. J Clin Invest. 127, 83-93.
    
  